Windsor Capital Management’s Amgen AMGN Stock Holding History

Windsor Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$919K	Sell	2,181 -1,126	-34%	-$449K	0.24%	60
2026 Q2	$1.2M	Sell	3,307 -413	-11%	-$141K	0.31%	50
2026 Q1	$1.31M	Buy	3,720 +10	+0.3%	+$3.56K	0.37%	49
2025 Q4	$1.21M	Buy	3,710 +2,117	+133%	+$672K	0.34%	49
2025 Q3	$450K	Buy	1,593 +65	+4%	+$18.9K	0.12%	90
2025 Q2	$427K	Buy	1,528 +154	+11%	+$43.6K	0.12%	90
2025 Q1	$428K	Buy	1,374 +120	+10%	+$35.4K	0.13%	91
2024 Q4	$327K	Buy	1,254 +11	+0.9%	+$3.26K	0.1%	98
2024 Q3	$401K	Buy	1,243 +265	+27%	+$86.7K	0.12%	94
2024 Q2	$306K	Buy	+978	New	+$287K	0.09%	96

Other funds holding AMGN

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $127B AUM 33.25% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Windsor Capital Management's AMGN Position: Q3 2026 in Review

Windsor Capital Management reduced its Amgen (AMGN) stake by 34% in Q3 2026, selling an estimated $449K and leaving 2,181 shares worth $919K. The position accounts for 0.24% of the portfolio, ranked #60.

Windsor Capital Management first reported a position in AMGN in Q2 2024 and has held it in 10 quarters since. The position peaked at $1.31M in Q1 2026. 2,318 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

Windsor Capital Management held 2,181 shares of Amgen worth $919K as of Q3 2026.
Windsor Capital Management sold 1,126 Amgen shares in Q3 2026, an estimated $449K.
Amgen made up 0.24% of Windsor Capital Management's portfolio in Q3 2026, its #60 holding.
Windsor Capital Management first reported a position in Amgen in Q2 2024 and has held it in 10 quarters since.
Windsor Capital Management's Amgen position peaked at $1.31M in Q1 2026.
2,318 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Windsor Capital Management's 13F filing for Q3 2026, filed 13 Oct 2026.